SCHEMBL9963643

SCHEMBL9963643

COCCN1CCN(C(=O)CNc2nc3c(C)c4nc(NCC(=O)N5CCCC5)sc4cc3s2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.45
TBK1 Q9UHD2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.36
KDM1A O60341 1/20 0.36
GAA P10253 1/20 0.36
ACKR3 P25106 1/20 0.36
TSHR P16473 1/20 0.36
UBE2M P61081 1/20 0.36
DCUN1D1 Q96GG9 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963644 0.90 PTGS2 (0.37) PTGS2TBK1CYP1A2CYP3A4CYP2D6
SCHEMBL9963555 0.88 PTGS2 (0.42) PTGS2BCHEACHEACKR3
SCHEMBL9963529 0.87 PTGS2 (0.41) PTGS2BCHEACHEALDH1A1GAA
SCHEMBL9963588 0.85 ACHE (0.46) PTGS2BCHEACHEALDH1A1RAB9A
SCHEMBL9963584 0.85 PTGS2 (0.51) PTGS2ALDH1A1RAB9AGAATSHR
SCHEMBL9963636 0.85 PTGS2 (0.46) PTGS2ALDH1A1RAB9AGAATSHR
SCHEMBL9963553 0.83 PTGS2 (0.47) PTGS2ALDH1A1RAB9AGAATSHR
SCHEMBL9963695 0.83 PTGS2 (0.49) PTGS2ALDH1A1RAB9AGAATSHR
SCHEMBL9963617 0.83 PTGS2 (0.47) PTGS2BCHEACHEALDH1A1ACKR3
SCHEMBL9963526 0.83 PTGS2 (0.47) PTGS2CYP3A4CYP2C19ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 PTGS2 2872/4885TBK1 4268/4885CYP1A2 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.